Trending...
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand - 102
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position - 101
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
ROXBORO, N.C., April 28, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a cGMP-certified manufacturer and distributor of the industry's most innovative and highest quality cannabinoid ingredients and finished products, announced today the completion of phase one of the toxicology and safety results for their cannabinoid ingredients CBG, CBN. and CBC. The Company contracted respected scientific and regulatory consulting firm, AIBMR Life Sciences, Inc, to conduct the battery of toxicological studies to investigate the safety of the consumption of the Company's cannabigerol (CBG), cannabinol (CBN), and cannabichromene (CBC) that will support a Generally Recognized as Safe (GRAS) Independent conclusion or New Dietary Ingredient (NDI) application.
The report concluded that the test articles were non-mutagenic, non-clastogenic and non-genotoxic. The toxicological assessment is the first known published data of its kind since the 1980 Rosenkrantz et al.'s publication with respect to toxicology data on CBD, Cannabichromene and hashish oil. The battery of GLP/OECD compliant studies is a major contribution in the advancement of the science of hemp-derived CBD.
More on ncarol.com
The investment in this toxicological assessment demonstrates OBX's commitment in furthering the science behind cannabinoid ingredients. Chelsea Pipkin, OBX VP of Quality Assurance, comments, "Until today, there have been no comprehensive toxicological safety assessments completed on minor cannabinoids, including CBG, CBN, and CBC. The completion and publication of these safety studies on this ingredient in a peer-reviewed academic journal specializing in toxicology is a monumental step forward in putting competent and reliable science behind a product. The public should applaud this effort as well as the time and expense it required."
OBX's Chief Executive Officer, Dave Neundorfer, echoed this sentiment. "We are thrilled to advance cannabinoid science and are very pleased with the safety results from this landmark study. This is an important milestone in our pursuit of GRAS or NDI status," he remarked. "As an organization, our commitment to safety remains paramount. We look forward to setting the bar for all cannabinoid manufacturers in the market and encourage them to conduct similar toxicological assessments on their own base raw materials."
More on ncarol.com
About Open Book Extracts
Headquartered in Roxboro, N.C., Open Book Extracts is a cGMP-certified manufacturer of premium plant-based cannabinoid products, aiming to be the industry's true north by delivering premium products, exceptional service, and industry-leading transparency. With control of the entire supply chain, a state-of-the-art extraction campus near North Carolina's Research Triangle, proprietary refinement and conversion methods backed by a growing IP portfolio, and a team of PhD chemists and seasoned business leaders, OBX is the trusted partner for global brands seeking to enter the marketplace.
For more information, visit https://openbookextracts.com/.
Media Contact:
Sheldon Baker
336-592-7317
[email protected]
SOURCE Open Book Extracts
The report concluded that the test articles were non-mutagenic, non-clastogenic and non-genotoxic. The toxicological assessment is the first known published data of its kind since the 1980 Rosenkrantz et al.'s publication with respect to toxicology data on CBD, Cannabichromene and hashish oil. The battery of GLP/OECD compliant studies is a major contribution in the advancement of the science of hemp-derived CBD.
More on ncarol.com
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
- Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
- The Seaside Art Gallery Presents
The investment in this toxicological assessment demonstrates OBX's commitment in furthering the science behind cannabinoid ingredients. Chelsea Pipkin, OBX VP of Quality Assurance, comments, "Until today, there have been no comprehensive toxicological safety assessments completed on minor cannabinoids, including CBG, CBN, and CBC. The completion and publication of these safety studies on this ingredient in a peer-reviewed academic journal specializing in toxicology is a monumental step forward in putting competent and reliable science behind a product. The public should applaud this effort as well as the time and expense it required."
OBX's Chief Executive Officer, Dave Neundorfer, echoed this sentiment. "We are thrilled to advance cannabinoid science and are very pleased with the safety results from this landmark study. This is an important milestone in our pursuit of GRAS or NDI status," he remarked. "As an organization, our commitment to safety remains paramount. We look forward to setting the bar for all cannabinoid manufacturers in the market and encourage them to conduct similar toxicological assessments on their own base raw materials."
More on ncarol.com
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
- Asheville-Based KayeDinero Surpasses 100-Track Goal as Detroit Lions Win 35-10 in Munich
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- Nious Media Expands Gaming Coverage With 2026 Game & Geek Expo Special
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
About Open Book Extracts
Headquartered in Roxboro, N.C., Open Book Extracts is a cGMP-certified manufacturer of premium plant-based cannabinoid products, aiming to be the industry's true north by delivering premium products, exceptional service, and industry-leading transparency. With control of the entire supply chain, a state-of-the-art extraction campus near North Carolina's Research Triangle, proprietary refinement and conversion methods backed by a growing IP portfolio, and a team of PhD chemists and seasoned business leaders, OBX is the trusted partner for global brands seeking to enter the marketplace.
For more information, visit https://openbookextracts.com/.
Media Contact:
Sheldon Baker
336-592-7317
[email protected]
SOURCE Open Book Extracts
Filed Under: Business
0 Comments
Latest on ncarol.com
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Apex Wellness Architect Hosts Intimate Tea & Intentions Tea Bar Experience to Close Out the Year
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Lake Norman Philharmonic Annual Holiday Concert 2026
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
- Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
